1999 Application and Approval Numbers
Rockville, MD-More new drugs have been approved by the Food and Drug Administration (FDA) for the U.S. market in a shorter time period than in the past. The FDA approved 83 drug applications with a median approval time of 12.0 months in 1999. This is compared to a median approval time of 12.0 months in 1998, 14.4 months in 1997 and 15.4 months in 1996. Twenty-eight of the approvals in 1999 were for priority drugs that were approved in a median time of 6.1 months. The priority and regular approvals in 1999 included 35 new molecular entities that were approved in a median time of 11.6 months compared to a median 12.0 months in 1998 and 13.4 months in 1997.
Twenty-four user fee and non-user fee product license applications were approved in a median time of 8.37 months in 1999. Three approvals were categorized as priority and were approved in a median time of 13.8 months. A total of thirty-nine new product license applications were received for review in 1999, 10 more than were received in 1998.
Forty-one premarket approval applications were approved in the median time of 9.1 months in 1999.
Beyond the Surface: Rethinking Environmental Hygiene Validation at Exchange25
June 30th 2025Environmental hygiene is about more than just shiny surfaces. At Exchange25, infection prevention experts urged the field to look deeper, rethink blame, and validate cleaning efforts across the entire care environment, not just EVS tasks.
A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides
June 26th 2025As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.